About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

Continuous biomanufacturing offers the potential for more agile, flexible production with improved robustness through the elimination of process steps, including hold steps, and the use of smaller ...

LOWER GWYNEDD, Pa.--(BUSINESS WIRE)--ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant of $2M ...

ALAMEDA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, the pioneer in continuous biomanufacturing, Bühler Group, the global solutions provider for food, feed, and advanced materials, and ATV ...

Pow.Bio, which specializes in AI-enabled continuous fermentation technology, and the Bühler Group, are teaming up to bring an integrated continuous precision fermentation platform to market. Officials ...

Metabolic Engineering; Biochemical Engineering; Biomanufacturing; Bioprocess Modeling, Optimization, and Control. Microbial Biomanufacturing platform: Engineering bacteria and yeast cells; Cellular ...

ALAMEDA, Calif. and UZWIL, Switzerland, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, the pioneer in AI-enabled continuous fermentation technology, and Bühler Group, the global solution provider for food ...

Transcenta inks strategic collaboration and non-exclusive licensing pact with EirGenix to advance integrated continuous biomanufacturing and expand global access to affordable biologics Princeton, New ...